Atopic Dermatitis Clinical Trial Patient Recruitment

Atopic dermatitis patient recruitment for moderate-to-severe, biologic-naive, and biologic-experienced clinical trials.

Who qualifies: Adults and adolescents with moderate-to-severe AD (IGA ≥3, EASI ≥16) with inadequate response to topicals.

Recruitment challenges: IGA/EASI scoring requirements and prior dupilumab washout periods.

Our approach: Dermatology referral networks, eczema patient community outreach, and IGA pre-screening.